Acute Coronary Syndorme
Acute Coronary Syndorme
Commensurate with advances in pharmacological and device therapies for both ACS and heart failure, the concept of using circulating biomarkers for diagnosis and risk stratification, as well as for targeting and monitoring therapy, has received great attention.
Editor's Choice
People who survive a heart attack face the greatest risk of dying from sudden cardiac death (SCD) during the first month after leaving the hospital, according to a long-term community study by Mayo...
After multivariable adjustment for demographic, hospital, co-morbidity, baseline health status, and treatment characteristics, UA patients had a greater prevalence of angina at 1 year than STEMI...
Latest News
12th November 2008 -
Prevention Of Coronary Heart Disease: New Findings On The Role Of Inflammation
12th November 2008 -
Rivaroxaban Phase II Dose-Ranging Study Demonstrates Encouraging Response Rates In Treatment Of Acute Coronary Syndrome Patients
Medical Guidelines
To provide evidence-based recommendations on the in-hospital management of patients with an acute coronary syndrome, as well as the duration of clopidogrel use beyond hospital discharge after non-ST...
To consider, on the basis of existing evidence, what role, if any, exercise testing plays in risk stratification in asymptomatic subjects. INTENDED USERS: Physicians. ...
